Insider Actions for Context Therapeutics Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 02/21/2023 |
Martin A. Lehr Chief Executive Officer; Director |
5,823 | Acquisition at $0.84 per share. | 4,891 |
| 02/13/2023 |
Martin A. Lehr Chief Executive Officer; Director |
5,606 | Acquisition at $0.87 per share. | 4,877 |
| 02/06/2023 |
Martin A. Lehr Chief Executive Officer; Director |
5,040 | Acquisition at $0.97 per share. | 4,888 |
| 01/30/2023 |
Martin A. Lehr Chief Executive Officer; Director |
7,027 | Acquisition at $0.7 per share. | 4,918 |
| 01/23/2023 |
Martin A. Lehr Chief Executive Officer; Director |
6,839 | Acquisition at $0.72 per share. | 4,924 |
| 01/17/2023 |
Martin A. Lehr Chief Executive Officer; Director |
6,783 | Acquisition at $0.74 per share. | 5,019 |
| 12/16/2022 |
Martin A. Lehr Chief Executive Officer; Director |
20,000 | Acquisition at $0.74 per share. | 14,800 |
| 12/16/2022 |
Jennifer Minai-Azary Chief Financial Officer |
25,000 | Acquisition at $0.74 per share. | 18,500 |
| 12/09/2022 |
Alex Levit Chief Legal Officer, Corp. Sec |
6,000 | Acquisition at $0.85 per share. | 5,100 |
| 08/19/2022 |
Martin A. Lehr Chief Executive Officer; Director |
13,000 | Acquisition at $1.85 per share. | 24,050 |
| 08/17/2022 |
Jennifer Minai-Azary Chief Financial Officer |
15,000 | Acquisition at $1.8 per share. | 27,000 |
